Skip to content
Longterm Wiki
grant

Ten30 Biosciences — General Support

Metadata

Source Tablegrants
Source IDauCg3yJBF7
Descriptionto Ten30 Biosciences, $5,000,000, 2025-04
Source URLcoefficientgiving.org/grants/
ParentULjDXpSLCI
Children
CreatedMar 12, 2026, 5:54 AM
UpdatedMar 19, 2026, 8:57 PM
SyncedMar 19, 2026, 8:57 PM

Record Data

idauCg3yJBF7
organizationIdCoefficient Giving(organization)
granteeIdTen30 Biosciences
orgEntityIdCoefficient Giving(organization)
orgDisplayName
granteeEntityId
granteeDisplayNameTen30 Biosciences
nameTen30 Biosciences — General Support
amount5000000
currencyUSD
period
date2025-04
status
sourcecoefficientgiving.org/funds/
notes[Scientific Research] Open Philanthropy recommended an investment of $5,000,000 in Ten30 Biosciences for general support. Ten30 Biosciences is a biotechnology company that is developing a novel oral drug to treat sickle cell disease, using an in-house platform that leverages AI and chemistry to disc
programIdB4pZkOtjSk
dataSourceId

Source Check Verdicts

confirmed95% confidence

Last checked: 4/9/2026

[deterministic-row-match] Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)

Debug info

Thing ID: auCg3yJBF7

Source Table: grants

Source ID: auCg3yJBF7